نتایج جستجو برای: meningococcal

تعداد نتایج: 4848  

Journal: :Journal of clinical microbiology 1984
R J Sugasawara C M Prato J E Sippel

Hybridomas were produced from spleen cells of BALB/c mice immunized with a membrane preparation from Neisseria meningitidis group A strain 4402 and S194/5.XXOBU.14 myeloma cells. The hybridomas were screened for secretion of antibodies suitable for an enzyme-linked immunosorbent assay (ELISA) diagnostic for group A meningococcal meningitis. One hybridoma antibody, 3G7, was directed against the ...

2011
Michael Bröker Brian Cooper Lisa M DeTora Jeffrey J Stoddard

Worldwide, invasive meningococcal disease affects about 500,000 people annually. Case fatality in developed countries averages 10%, and higher rates are reported in less prosperous regions. According to the World Health Organization, the most important pathogenic serogroups are A, B, C, W-135, X, and Y. Clinical features of invasive meningococcal disease make diagnosis and management difficult....

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009
Tom Sprong Tom Eirik Mollnes Chris Neeleman Dorine Swinkels Mihai G Netea Jos W M van der Meer Marcel van Deuren

BACKGROUND Systemic activation of complement during meningococcal disease is associated with severe disease and poor outcome. The exact mechanism of activation of complement is unknown but is important for future therapies aimed at modulating the complement system in this disease. METHODS We studied complement activation in a group of 22 patients, including 18 with meningococcal septic shock ...

2014
Carine P Hedari Rima W Khinkarly Ghassan S Dbaibo

Invasive meningococcal disease is a serious infection that occurs worldwide. It is caused by Neisseria meningitidis, of which six serogroups (A, B, C, W-135, X, and Y) are responsible for most infections. The case fatality rate of meningococcal disease remains high and can lead to significant sequelae. Vaccination remains the best strategy to prevent meningococcal disease. Polysaccharide vaccin...

2017
Vanina Masson-Behar Hervé Jacquier Pascal Richette Jean-Marc Ziza Valérie Zeller Christophe Rioux Baptiste Coustet Philippe Dieudé Sébastien Ottaviani

Arthritis secondary to invasive meningococcemia is rare and has been described as a direct result of bacteremia or as immunoallergic-type arthritis, related to the immune complex. Only a few case series have been reported.This multicenter study aimed to describe the clinical characteristics and therapeutic outcomes of arthritis secondary to meningococcal infection.We performed a 5-year retrospe...

Journal: :Pediatrics 2015
Jessica R MacNeil Nancy Bennett Monica M Farley Lee H Harrison Ruth Lynfield Megin Nichols Sue Petit Arthur Reingold William Schaffner Ann Thomas Tracy Pondo Leonard W Mayer Thomas A Clark Amanda C Cohn

BACKGROUND The incidence of meningococcal disease is currently at historic lows in the United States; however, incidence remains highest among infants aged <1 year. With routine use of Haemophilus influenzae type b and pneumococcal vaccines in infants and children in the United States, Neisseria meningitidis remains an important cause of bacterial meningitis in young children. METHODS Data we...

Journal: :The Pediatric infectious disease journal 2012
Andrew Terranella Susan E Beekmann Philip M Polgreen Amanda Cohn Henry M Wu Thomas A Clark

BACKGROUND Although empiric treatment regimens for acute bacterial meningitis are well established, there are many uncertainties regarding management of meningococcal disease. A survey was conducted among infectious disease specialists to assess meningococcal disease practice patterns and availability of antimicrobial susceptibility testing for Neisseria menigitidis. METHODS An online survey ...

Journal: :Pediatrics 2015
Lucy A McNamara Alice M Shumate Peter Johnsen Jessica R MacNeil Manisha Patel Tina Bhavsar Amanda C Cohn Jill Dinitz-Sklar Jonathan Duffy Janet Finnie Denise Garon Robert Hary Fang Hu Hajime Kamiya Hye-Joo Kim John Kolligian Janet Neglia Judith Oakley Jacqueline Wagner Kathy Wagner Xin Wang Yon Yu Barbara Montana Christina Tan Robin Izzo Thomas A Clark

BACKGROUND In 2013-2014, an outbreak of serogroup B meningococcal disease occurred among persons linked to a New Jersey university (University A). In the absence of a licensed serogroup B meningococcal (MenB) vaccine in the United States, the Food and Drug Administration authorized use of an investigational MenB vaccine to control the outbreak. An investigation of the outbreak and response was ...

2010
Susu M. Zughaier Pavel Svoboda Jan Pohl David S. Stephens William M. Shafer

Capsular polysaccharides (CPS) are a major virulence factor in meningococcal infections and form the basis for serogroup designation and protective vaccines. Our work has identified meningococcal CPS as a pro-inflammatory ligand that functions through TLR2 and TLR4-MD2-dependent activation. We hypothesized that human cationic host defense peptides interact with CPS and influence its biologic ac...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2004
Nico Stollenwerk Martin C J Maiden Vincent A A Jansen

Neisseria meningitidis, the meningococcus, is a major cause of bacterial meningitis and septicemia worldwide. Infection in most cases leads to asymptomatic carriage and only rarely to disease. Meningococcal disease often occurs in outbreaks, which are both sporadic and highly unpredictable. The occurrence of disease outbreaks in a host population in which the etiological agent is widely carried...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید